Marija Balic: Ensuring Consistent Testing for Women with Metastatic Hormone Receptor–Positive Cancer
Marija Balic, Co-director of Magee Womens Cancer Program at University of Pittsburgh School of Medicine, shared a post on LinkedIn about recent paper she and colleagues co-authored:
“Happy to share, liquid biopsy testing is not easily available for breast cancer patients around the world.
One way to make sure women with metastatic hormone receptor positive cancer get tested in controlled way.”
Title: Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2− breast cancer: insights and implications
Authors: Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, Christine Beichler, Dominik Hlauschek, Christoph Suppan, Lara Pancheri, Daniel Egle, Carmen Albertini, Rupert Bartsch, Angelika Martina Starzer, Philipp Jakob Jost, Gabriel Rinnerthaler, Ellen Heitzer, Nadia Dandachi, Marija Balic
Read The Full Article at NPJ Breast Cancer.
More Posts Featuring Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023